Fiorenza Barraco

2.7k citations
94 papers · 1.9k · 4 hit papers · h-index 22

Impact in

  • Hematology top 2%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 2%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Vascular Anomalies and Treatments

Papers in

    • Acute Myeloid Leukemia Research 29
    • Hematopoietic Stem Cell Transplantation 29
    • Chronic Myeloid Leukemia Treatments 11
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 16

Fiorenza Barraco

89 papers receiving 1.9k citations

Fiorenza Barraco's Hit Papers

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study 2023 · 141 citations
1410+1+3Years since publication50100150200

Peers

Fiorenza Barraco
Comparison fields: 5 of 85
  • Hematology 756
  • Genetics 656
  • Rheumatology 562
  • Transplantation 59
  • Immunology 369
Replace Hirohito Yamazaki with:
Hirohito Yamazaki Japan
Paolo Durigutto Italy
David Michonneau France
Isabel Krsnik Spain
Nadežda Basara Germany
Cristina Arbona Spain
Marie Thérèse Rubio France
Jiří Pavlů United Kingdom
Woo-Sung Min South Korea
Kazuhiro Masuoka Japan
Fiorenza Barraco relative to Hirohito Yamazaki Japan Hirohito Yamazaki's profile →
Citations per field
00.5×2×4×6×7×
Hirohito Yamazaki · 1×
Citations per year

Countries citing papers authored by Fiorenza Barraco

Since Specialization
Citations

This map shows the geographic impact of Fiorenza Barraco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiorenza Barraco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiorenza Barraco more than expected).

Fields of papers citing papers by Fiorenza Barraco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiorenza Barraco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiorenza Barraco. The network helps show where Fiorenza Barraco may publish in the future.

Co-authors

The 25 scholars most cited alongside Fiorenza Barraco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fiorenza Barraco Line = papers co-authored together Fiorenza Barraco links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Therapeutic options in VEXAS syndrome: insights from a retrospective series
Hit paper breakdown →
2021218
2
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
Hit paper breakdown →
2022181
3
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Hit paper breakdown →
2022168
4
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
Hit paper breakdown →
2023141
5 2021126
6 2015121
7 2014120
8 201563
9 202360
10 201142
11 201638
12 202032
13 202130
14 201226
15 201526
16 201824
17 201824
18 202023
19 199922
20 201322

About Fiorenza Barraco

Fiorenza Barraco is a scholar working on Hematology, Genetics, Oncology, Immunology and Epidemiology, having authored 94 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (29 papers), Hematopoietic Stem Cell Transplantation (29 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Chronic Myeloid Leukemia Treatments (11 papers), Polyomavirus and related diseases (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Neutropenia and Cancer Infections (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Hematology (756 citations), Genetics (656 citations), Rheumatology (562 citations), Transplantation (59 citations) and Immunology (369 citations). Fiorenza Barraco has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Maël Heiblig, Mauricette Michallet, Xavier Thomas, Pierre Sujobert, Estelle Bourbon, Jean‐Christophe Lega, Yvan Jamilloux, Pascal Sève, Thomas Barba and Cécile‐Audrey Durel. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Bone Marrow Transplantation, American Journal of Hematology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact